Working… Menu

Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies (AEGIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01065025
Recruitment Status : Completed
First Posted : February 9, 2010
Last Update Posted : April 13, 2015
Information provided by:

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2015
Actual Study Completion Date : April 2015